Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc. is a global healthcare company that develops and produces stabilized hypochlorous acid (HOCl) products. These products are used in various applications such as wound care, eye care, dermatological conditions, podiatry, animal health care, and as non-toxic disinfectants. The company's products are clinically proven to safely reduce itch, pain, scarring, and irritation without damaging healthy tissue. In-vitro and clinical studies demonstrate that HOCl can safely manage skin abrasions, lacerations, minor irritations, cuts, and intact skin. Sonoma Pharmaceuticals sells its products directly or through partners in over 55 countries worldwide. The company has two active wholly-owned subsidiaries: Oculus Technologies of Mexico, S.A. de C.V., and Sonoma Pharmaceuticals Netherlands, B.V. Its principal executive offices are located in Boulder, Colorado. The company's fiscal year ends on March 31. In March 2026, Sonoma Pharmaceuticals launched its advanced HOCl-based burn relief hydrogel in CVS and Walmart stores across the United States.